Skip to main content
. 2011 Jul;77(13):4313–4317. doi: 10.1128/AEM.00421-11

Fig. 3.

Fig. 3.

Inhibition of PMCA due to the presence of a subtilisin enzyme solution. Representative Western blots (n = 3) of 1:100 HY TME agent samples spiked with a serial dilution of the Prionzyme solution and subjected to one round of PMCA are shown. Arrows indicate the Prionzyme treatment dose (10%) and calculated postwash concentration (10−4.9).